These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2004-002912-27||Open-Label Extension Study to Investigate the Continued Safety and Effect of ONO 2506PO (1200 mg OD).||not-yet-due|
|Listed as ongoing, but also has a completion date||2006-002660-26||A MULTI-CENTRE, RANDOMISED, DOUBLE BLIND, PLACEBO CONTROLLED, PARALLEL GROUP STUDY TO INVESTIGATE EFFICACY AND SAFETY OF ONO-2506PO COMPARED TO PLACEBO, IN THE PRESENCE OF RILUZOLE, TO PATIENTS DIAGNO...||2008-09-03||bad-data|
|Not reported||2007-002417-39||A MULTI-CENTRE RANDOMISED DOUBLE BLIND, PLACEBO AND ACTIVE CONTROLLED PARALLEL GROUP STUDY TO INVESTIGATE EFFICACY AND SAFETY OF ONO-5334 IN POST MENOPAUSAL WOMEN WITH OSTEOPENIA OR OSTEOPOROSIS||2010-08-26||due-trials|
|Listed as ongoing, but also has a completion date||2007-004723-37||A Phase II multi-centre, extension study to investigate the long term safety of ONO-2506PO in patients diagnosed with Amyotrophic Lateral Sclerosis (ALS).||2008-09-03||bad-data|
|Not reported||2007-006538-33||A RANDOMISED, MULTI-CENTRE, DOUBLE-BLIND, PLACEBO- AND ACTIVE-CONTROLLED, 5-WAY, PARALLEL GROUP STUDY TO INVESTIGATE THE EFFICACY, SAFETY AND TOLERABILITY OF ONO-8539 IN PATIENTS WITH OVERACTIVE BLADD...||2010-05-25||due-trials|
|Listed as ongoing, but also has a completion date||2009-014339-19||A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF ONO-4641 IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS||2011-11-29||bad-data|
|Reported results||2010-018705-11||A SAFETY AND EFFICACY EXTENSION STUDY OF ONO-4641 IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS||2015-01-30||due-trials|
|Not reported||2012-002273-54||A randomised, double-blind, placebo controlled, double dummy, four period crossover study to evaluate the efficacy, safety and tolerability of oral repeat doses of ONO-4053 and Cetirizine in subjects ...||2013-03-12||due-trials|
|Ongoing||2015-003339-36||A Multicenter, Randomized, Open-label Study in Patients with esophageal Cancer refractory or intolerant to Combination Therapy with Fluoropyrimidine and Platinum-based Drugs||not-yet-due|
|Completed, reported early||2016-002675-97||A randomised, double-blind, placebo controlled, parallel group, multi-centre, study to evaluate the efficacy, safety, tolerability and pharmacokinetics of ONO-4474 in patients with pain due to osteoar...||2018-01-09||not-yet-due|
|Trial is outside EEC, and reported results||2018-000662-11||ONO-7436 Phase III Study – A multicenter, open-label, uncontrolled study for the prevention of chemotherapy-induced nausea and vomiting||bad-data|
|Trial is outside EEC, and reported results||2018-000663-80||ONO-7847 Japanese Clinical Study in Pediatric Patients Multicenter, open-label, uncontrolled study for the prevention of CINV||bad-data|